Change requirements relating to compounding and delegated dispensing permits under the Pharmacy Practice Act

Nebraska's LB 697 amends pharmacy practice regulations to update compounding standards and delegated dispensing rules. It requires pharmacists to follow specific U.S. Pharmacopeia standards for compounding (effective Jan. 2023) and prohibits compounding certain drugs, like FDA-withdrawn products or copies of approved drugs during shortages. The bill also revises delegated dispensing permits for public health clinics, limiting dispensing to contraceptive refills, mandating detailed labeling requirements, and requiring a pharmacist's daily availability to answer questions. These changes directly affect pharmacists, pharmacy boards, and public health clinics operating under delegated dispensing permits.